Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Fourier Intelligence
company
About
Fourier Intelligence is a Technology and design company
- 101 - 250
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥30M
- Industries
- Medical,Medical Device,Rehabilitation
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Fourier Intelligence is a Shanghai-based technology and design company providing exoskeleton robotic product and service on rehabilitation & orthoses. Its products include upper-limb rehab robotics and lower-limb exoskeleton robot, which can help the disabled go beyond of the physical limits, stand up and walk again. Its exoskeleton products can also decrease fatigue and increase productivity whilst unloading supplies or enabling workers/soldiers to carry heavy objects.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥30M
Fourier Intelligence has raised a total of
¥30M
in funding over 2 rounds. Their latest funding was raised on
Mar 2, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 2, 2018 | Series A | ¥30M | 1 |
Prosperico Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Fourier Intelligence is funded by 1 investors.
Prosperico Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Prosperico Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
